Reducing Unnecessary Testing for Low-Risk Surgeries
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on reducing unnecessary tests before low-risk surgeries such as breast lumpectomies, laparoscopic gallbladder removal, and hernia repairs. The researchers aim to evaluate a new strategy, called Active de-Implementation, which includes tools like clinician education and performance feedback to effectively reduce these tests. Surgical sites with a history of conducting over 30% unnecessary tests for these procedures will participate. The trial will proceed in phases, each including preparation, active interventions, and follow-up to assess the sustainability of changes. As an unphased trial, this study provides a unique opportunity to enhance surgical practices and patient care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this de-implementation strategy is safe?
Research shows that the strategies tested in this study are generally safe for participants. Studies have found that altering procedures and reducing unnecessary medical tests can significantly decrease these tests without harming patients. For example, one study reported a 19.6% reduction in unnecessary tests. Importantly, there were no major negative effects on the patient-doctor relationship, suggesting these changes are well-accepted. Thus, while the trial aims to reduce unnecessary testing, existing evidence indicates it does not pose risks to patient safety.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on reducing unnecessary testing for low-risk surgeries. Unlike traditional approaches that often involve extensive pre-surgery testing, this method aims to streamline care by actively de-implementing redundant procedures. By minimizing unnecessary tests, the approach has the potential to enhance patient experience, reduce healthcare costs, and focus medical resources where they are truly needed. This innovative strategy could lead to more efficient surgical protocols and better patient outcomes.
What evidence suggests that this trial's de-implementation strategy could be effective in reducing unnecessary preoperative testing?
Research has shown that reducing unnecessary medical tests, such as those conducted before surgery, can significantly decrease their frequency. One study found a typical reduction of 19.6% in these low-value practices. This trial will implement active de-implementation strategies to achieve similar reductions by changing procedures and educating doctors. Importantly, these unnecessary tests do not improve patient health or prevent problems. Overall, strategies to reduce these tests are effective and safe for patients.26789
Who Is on the Research Team?
Lesly Dossett, MD, MPH
Principal Investigator
University of Michigan
Hari Nathan, PhD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for patients scheduled for low-risk surgeries like inguinal hernia repair, breast lump removal, or laparoscopic cholecystectomy. It's focused on reducing unnecessary preoperative tests using a new strategy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Preparation
Preparation phase includes usual care and preparation activities before the intervention
Active De-implementation Interventions
Implementation of multi-level, multi-component strategies to reduce unnecessary preoperative testing
Sustainment
Phase to maintain the reduction in unnecessary testing after active interventions
Follow-up
Participants are monitored for the number of tests within 30 days of surgery and other secondary outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Active de-Implementation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator
Blue Cross Blue Shield of Michigan Foundation
Collaborator